title: Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling.
abstract: Many anticancer drugs, such as doxorubicin (DXR), intercalate into nuclear DNA of cancer cells, thereby inhibiting their growth. However, it is not well understood how such drugs interact with mitochondrial DNA (mtDNA). Using cell and molecular studies of cultured cells, we show that DXR and other DNA intercalators, such as ethidium bromide, can rapidly intercalate into mtDNA within living cells, causing aggregation of mtDNA nucleoids and altering the distribution of nucleoid proteins. Remodelled nucleoids excluded DXR and maintained mtDNA synthesis, whereas non-remodelled nucleoids became heavily intercalated with DXR, which inhibited their replication, thus leading to mtDNA depletion. Remodelling was accompanied by extensive mitochondrial elongation or interconnection, and was suppressed in cells lacking mitofusin 1 and optic atrophy 1 (OPA1), the key proteins for mitochondrial fusion. In contrast, remodelling was significantly increased by p53 or ataxia telangiectasia mutated inhibition (ATM), indicating a link between nucleoid dynamics and the genomic DNA damage response. Collectively, our results show that DNA intercalators can trigger a common mitochondrial response, which likely contributes to the marked clinical toxicity associated with these drugs.
authors.affiliation: Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Level 3, Women's Centre, John Radcliffe Hospital, Headington, Oxford, UK. Neil.Ashley@clin-pharm.ox.ac.uk
authors.forename: N
authors.initials: N
authors.lastname: Ashley
authors.forename: J
authors.initials: J
authors.lastname: Poulton
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D064007:Ataxia Telangiectasia Mutated Proteins; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism; D002460:Cell Line; D004249:DNA Damage / Q000187:drug effects*; D004272:DNA, Mitochondrial / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D004317:Doxorubicin / Q000494:pharmacology*; D004996:Ethidium / Q000494:pharmacology*; D020558:GTP Phosphohydrolases / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007364:Intercalating Agents / Q000494:pharmacology*; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D026901:Membrane Transport Proteins / Q000235:genetics / Q000378:metabolism; D033681:Mitochondrial Membrane Transport Proteins; D024101:Mitochondrial Proteins / Q000235:genetics / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D051381:Rats; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D000903:Antibiotics, Antineoplastic; D018797:Cell Cycle Proteins; D004272:DNA, Mitochondrial; D004268:DNA-Binding Proteins; D007364:Intercalating Agents; D008565:Membrane Proteins; D026901:Membrane Transport Proteins; C489709:Mfn1 protein, rat; D033681:Mitochondrial Membrane Transport Proteins; D024101:Mitochondrial Proteins; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins; D004317:Doxorubicin; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases; D020558:GTP Phosphohydrolases; C415198:OPA1 protein, human; C498811:Opa1 protein, rat; C470017:Mfn1 protein, human; D004996:Ethidium
references.citation: J Cell Biol. 2007 Aug 27;178(5):757-64
references.pmid: 17709430
references.citation: J Clin Invest. 2007 Dec;117(12):3730-41
references.pmid: 18037988
references.citation: J Cell Biol. 2003 Jan 20;160(2):189-200
references.pmid: 12527753
references.citation: Biochim Biophys Acta. 1998 Oct 1;1400(1-3):173-84
references.pmid: 9748560
references.citation: Nucleic Acids Res. 2001 Jan 15;29(2):E1
references.pmid: 11139631
references.citation: EMBO J. 2009 Jun 3;28(11):1589-600
references.pmid: 19360003
references.citation: Hum Mol Genet. 1994 Oct;3(10):1763-9
references.pmid: 7849699
references.citation: J Biol Chem. 2004 Dec 17;279(51):53272-81
references.pmid: 15489221
references.citation: Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):15927-32
references.pmid: 15509649
references.citation: N Engl J Med. 1998 Sep 24;339(13):900-5
references.pmid: 9744975
references.citation: Biochem J. 1987 Jul 1;245(1):309-12
references.pmid: 3663157
references.citation: J Biol Chem. 2008 Feb 8;283(6):3665-3675
references.pmid: 18063578
references.citation: Exp Cell Res. 2003 Sep 10;289(1):133-42
references.pmid: 12941611
references.citation: Exp Cell Res. 2005 Feb 15;303(2):432-46
references.pmid: 15652355
references.citation: Adv Drug Deliv Rev. 2001 Jul 2;49(1-2):87-105
references.pmid: 11377805
references.citation: J Biol Chem. 2005 Jul 15;280(28):26185-92
references.pmid: 15899901
references.citation: Mol Biol Cell. 2003 Apr;14(4):1583-96
references.pmid: 12686611
references.citation: C R Biol. 2006 Sep;329(9):657-68
references.pmid: 16945832
references.citation: Nephrol Dial Transplant. 2004 Feb;19(2):329-36
references.pmid: 14736955
references.citation: Mutat Res. 2006 Apr 11;596(1-2):57-63
references.pmid: 16488450
references.citation: EMBO J. 2005 Oct 5;24(19):3482-92
references.pmid: 16163384
references.citation: Pediatrician. 1991;18(1):49-52
references.pmid: 1983861
references.citation: J Biol Chem. 2003 Mar 7;278(10):7743-6
references.pmid: 12509422
references.citation: Cell Death Differ. 2008 Dec;15(12):1865-74
references.pmid: 19011642
references.citation: J Cell Sci. 2004 Jun 1;117(Pt 13):2653-62
references.pmid: 15138283
references.citation: Hum Mol Genet. 2008 Aug 15;17(16):2496-506
references.pmid: 18487244
references.citation: J Cell Sci. 2008 Jun 1;121(11):1861-8
references.pmid: 18477605
references.citation: J Mol Cell Cardiol. 1981 Sep;13(9):855-60
references.pmid: 7299833
references.citation: Science. 2005 Feb 4;307(5710):714-7
references.pmid: 15692048
references.citation: Nucleic Acids Res. 2000 Feb 15;28(4):1019-25
references.pmid: 10648796
references.citation: Mol Cancer Ther. 2002 Oct;1(12):1097-104
references.pmid: 12481433
references.citation: Hum Mol Genet. 2007 Jun 15;16(12):1400-11
references.pmid: 17483096
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14849-54
references.pmid: 12403821
references.citation: J Histochem Cytochem. 2007 Jun;55(6):629-39
references.pmid: 17312011
references.citation: Toxicol Lett. 2001 May 19;121(3):151-7
references.pmid: 11369469
references.citation: AIDS. 2009 Apr 27;23(7):779-88
references.pmid: 19287302
references.citation: Biochem Biophys Res Commun. 2009 Jan 16;378(3):450-5
references.pmid: 19032935
references.citation: Integr Cancer Ther. 2005 Jun;4(2):110-30
references.pmid: 15911925
references.citation: Pharmacol Toxicol. 2003 Sep;93(3):105-15
references.pmid: 12969434
references.citation: Cancer Res. 1992 Apr 15;52(8):2243-7
references.pmid: 1559227
references.citation: Nature. 2004 May 27;429(6990):417-23
references.pmid: 15164064
references.citation: J Pathol. 2005 Dec;207(4):436-44
references.pmid: 16278810
references.citation: J Cell Biol. 2007 Jan 15;176(2):141-6
references.pmid: 17210950